Wells Fargo’s iRadimed IRMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.39M | Buy |
24,880
+15,184
| +157% | +$1.52M | ﹤0.01% | 3129 |
|
|
2025
Q4 | $943K | Buy |
9,696
+4,009
| +70% | +$344K | ﹤0.01% | 4017 |
|
|
2025
Q3 | $405K | Buy |
5,687
+769
| +16% | +$51.2K | ﹤0.01% | 4453 |
|
|
2025
Q2 | $294K | Buy |
4,918
+452
| +10% | +$24.8K | ﹤0.01% | 4512 |
|
|
2025
Q1 | $234K | Buy |
4,466
+104
| +2% | +$5.84K | ﹤0.01% | 4596 |
|
|
2024
Q4 | $240K | Buy |
4,362
+1,270
| +41% | +$66.8K | ﹤0.01% | 4683 |
|
|
2024
Q3 | $155K | Sell |
3,092
-63
| -2% | -$2.91K | ﹤0.01% | 4746 |
|
|
2024
Q2 | $139K | Sell |
3,155
-24
| -0.8% | -$1.02K | ﹤0.01% | 4750 |
|
|
2024
Q1 | $140K | Buy |
3,179
+183
| +6% | +$8.09K | ﹤0.01% | 4693 |
|
|
2023
Q4 | $142K | Buy |
2,996
+433
| +17% | +$18.2K | ﹤0.01% | 4683 |
|
|
2023
Q3 | $114K | Sell |
2,563
-1,582
| -38% | -$73.5K | ﹤0.01% | 4699 |
|
|
2023
Q2 | $198K | Buy |
4,145
+1,561
| +60% | +$70.4K | ﹤0.01% | 4599 |
|
|
2023
Q1 | $102K | Buy |
2,584
+1,367
| +112% | +$49.7K | ﹤0.01% | 4790 |
|
|
2022
Q4 | $34.4K | Sell |
1,217
-472
| -28% | -$13.5K | ﹤0.01% | 5026 |
|
|
2022
Q3 | $51K | Sell |
1,689
-53
| -3% | -$1.85K | ﹤0.01% | 4944 |
|
|
2022
Q2 | $60K | Sell |
1,742
-19,334
| -92% | -$693K | ﹤0.01% | 4940 |
|
|
2022
Q1 | $945K | Sell |
21,076
-2,790
| -12% | -$129K | ﹤0.01% | 3942 |
|
|
2021
Q4 | $1.1M | Buy |
23,866
+5,898
| +33% | +$238K | ﹤0.01% | 4031 |
|
|
2021
Q3 | $604K | Buy |
17,968
+16,718
| +1,337% | +$569K | ﹤0.01% | 4554 |
|
|
2021
Q2 | $37K | Sell |
1,250
-5,552
| -82% | -$153K | ﹤0.01% | 5673 |
|
|
2021
Q1 | $175K | Sell |
6,802
-9,694
| -59% | -$232K | ﹤0.01% | 5219 |
|
|
2020
Q4 | $376K | Sell |
16,496
-2,194
| -12% | -$50.7K | ﹤0.01% | 4731 |
|
|
2020
Q3 | $400K | Sell |
18,690
-4,958
| -21% | -$111K | ﹤0.01% | 4516 |
|
|
2020
Q2 | $549K | Buy |
23,648
+11,394
| +93% | +$245K | ﹤0.01% | 4260 |
|
|
2020
Q1 | $261K | Sell |
12,254
-194
| -2% | -$4.62K | ﹤0.01% | 4499 |
|
|
2019
Q4 | $291K | Buy |
12,448
+371
| +3% | +$8.67K | ﹤0.01% | 4742 |
|
|
2019
Q3 | $254K | Buy |
12,077
+675
| +6% | +$13.8K | ﹤0.01% | 4816 |
|
|
2019
Q2 | $234K | Sell |
11,402
-1,033
| -8% | -$24.3K | ﹤0.01% | 4887 |
|
|
2019
Q1 | $350K | Sell |
12,435
-16,535
| -57% | -$433K | ﹤0.01% | 4539 |
|
|
2018
Q4 | $709K | Buy |
28,970
+26,192
| +943% | +$704K | ﹤0.01% | 4102 |
|
|
2018
Q3 | $104K | Buy |
2,778
+1,849
| +199% | +$49.9K | ﹤0.01% | 5339 |
|
|
2018
Q2 | $19K | Buy |
929
+429
| +86% | +$7.58K | ﹤0.01% | 5828 |
|
|
2018
Q1 | $7K | Hold |
500
| – | – | ﹤0.01% | 6003 |
|
|
2017
Q4 | $8K | Hold |
500
| – | – | ﹤0.01% | 5965 |
|
|
2017
Q3 | $5K | Hold |
500
| – | – | ﹤0.01% | 6022 |
|
|
2017
Q2 | $4K | Sell |
500
-1,918
| -79% | -$16.4K | ﹤0.01% | 5961 |
|
|
2017
Q1 | $21K | Buy |
2,418
+1,017
| +73% | +$9.43K | ﹤0.01% | 5700 |
|
|
2016
Q4 | $16K | Hold |
1,401
| – | – | ﹤0.01% | 5680 |
|
|
2016
Q3 | $24K | Buy |
+1,401
| New | +$25.9K | ﹤0.01% | 5552 |
|
|
2016
Q2 | – | Sell |
-154
| Closed | -$3K | – | 6205 |
|
|
2016
Q1 | $3K | Sell |
154
-48
| -24% | -$919 | ﹤0.01% | 5966 |
|
|
2015
Q4 | $6K | Buy |
202
+184
| +1,022% | +$5.2K | ﹤0.01% | 5846 |
|
|
2015
Q3 | $0 | Sell |
18
-123
| -87% | -$2.94K | ﹤0.01% | 6311 |
|
|
2015
Q2 | $3K | Buy |
+141
| New | +$2.58K | ﹤0.01% | 6103 |
|
Other funds holding IRMD
CCM
VCM
NTCM
Wells Fargo's IRMD Position: Q1 2026 in Review
Wells Fargo increased its iRadimed (IRMD) stake by 157% in Q1 2026, buying an estimated $1.52M and bringing the position to 24,880 shares worth $2.39M. The position accounts for ﹤0.01% of the portfolio, ranked #3129.
Wells Fargo first reported a position in IRMD in Q2 2015 and has held it in 43 quarters since. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.
- Wells Fargo held 24,880 shares of iRadimed worth $2.39M as of Q1 2026.
- Wells Fargo bought 15,184 iRadimed shares in Q1 2026, an estimated $1.52M.
- iRadimed made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #3129 holding.
- Wells Fargo first reported a position in iRadimed in Q2 2015 and has held it in 43 quarters since.
- 228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.
Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.